Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Rheumatology International|December 30, 2016
Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort studyJ van den Hoek, H C Boshuizen, L D Roorda, et al.
Circulation|November 1, 1994
Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgeryJ S Ginsberg, M T Nurmohamed, M Gent, et al.
Lancet (London, England)|February 8, 1992
Dermatan sulphate in haemodialysisD A Lane, K Ryan, H Ireland, et al.
Annals of the Rheumatic Diseases|May 10, 2014
Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-upE L Kneepkens, C L M Krieckaert, D van der Kleij, et al.
Scandinavian Journal of Rheumatology|July 27, 2017
Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumabJ Ruwaard, M J l'Ami, A F Marsman, et al.
Annals of the Rheumatic Diseases|July 8, 2009
Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort studyG M Bartelds, C A Wijbrandts, M T Nurmohamed, et al.
Rheumatology International|November 3, 2021
Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitationM Baniaamam, S C Heslinga, T C Konings, et al.
Annals of the Rheumatic Diseases|April 9, 2008
Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockadeI C van Eijk, M J L Peters, E H Serné, et al.
Scandinavian Journal of Rheumatology|July 22, 2016
Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort studyE L Kneepkens, Iam van den Oever, C H Plasencia, et al.
Annals of the Rheumatic Diseases|May 20, 2005
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitisJ C van Denderen, M van der Paardt, M T Nurmohamed, et al.
Pageof 10